CMTDIG

NEFL | 2004

What Is CMTDIG?

CMTDIG is a type of CMT caused by autosomal dominant mutations in the NEFL gene. This gene provides instructions for making neurofilament light chain, a structural protein that helps maintain the size and shape of nerve axons. Mutations in the NEFL gene disrupt this function, leading to impaired nerve signal transmission.

CMTDIG is autosomal dominant, meaning that just one of the gene’s two copies needs a mutation to cause this subtype.

Clinical Features

The age of symptom onset in CMTDIG is variable, ranging from childhood to adulthood. Symptoms typically begin in the lower extremities and progress over time to involve the upper limbs. Nerve conduction studies usually show somewhat slowed conduction velocities, consistent with an intermediate form of CMT.

CMTDIG symptoms may include:

  • Weakness in the feet and lower legs
  • Muscle atrophy
  • Foot drop
  • Reduced or absent reflexes
  • Reduced sensation
  • A steppage-style walking pattern
  • Foot deformities, including high arches, and hammertoes (clawed toes)
  • Progressive involvement of the hands and forearms
  • Difficulty with fine motor skills and manual dexterity
  • Additional symptoms not listed here

Disease Course

CMTDIG shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression is generally slow, and life expectancy is not reduced.

Clinical Basics

Subtype
CMTDIG

Classification
CMTDI

Neuropathy Type
Intermediate

Inheritance Pattern
autosomal dominant

Genetic Context

HGNC-Approved Gene Symbol
NEFL

Gene Full Name
Neurofilament Light Chain

HGNC Gene Alias(es)
NFL, NF68

Chromosome
8p21.2

Zygosity of Responsible Variant
Heterozygous

Variant Mechanism
Loss of Function (LoF), Toxic Gain of Function (GoF)

ClinVar Pathogenic Variants

View CMTDIG ClinVar Variants

CMTDIG OMIM Entry

CMTDIG OMIM

NEFL OMIM Entry

NEFL OMIM

More Info

CMTDIG Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

The Novel Neurofilament Light (NEFL) Mutation Glu397Lys is Associated With a Clinically and Morphologically Heterogeneous Type of Charcot-Marie-Tooth Neuropathy

Authors

Züchner, S., Vorgerd, M., Sindern, E., & Schröder, J. M.

Publication Date
February 1, 2004

Updated: July 18, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


Close-up of a doctor’s hand holding a prescription pad while a patient’s wrist is wrapped with metal chains.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Illustrated graphic showing large ‘404’ numerals with people interacting with data screens and servers, alongside text reading ‘CMT Genetic Testing Error 404: Gene Not Found’ and ‘Examining Why Less Than Half of All Who Have Charcot-Marie-Tooth Disease Are Not Able to Obtain Genetic Confirmation of Their Disease.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.


Illustrated cover graphic showing a split landform with branching directional arrows, two people with question marks above their heads, and the title ‘SORD Deficiency: Decoding This Newly Discovered and Confusing CMT Subtype.


CMT-SORD: What Is This Unique CMT Subtype?

CMT-SORD is a newly discovered CMT subtype driven by toxic sorbitol accumulation. This article explains how "SORD" works, why this subtype is different, and how it led to the fastest-moving therapeutic program in CMT history.